Nektar Therapeutics | NKTR - Чистый доход

Биржевая цена
70.62
Изменение за день
-3.71 -4.99%
Ежемесячно
-15.92%
Ежегодный
587.30%
Q2 прогноз
80.19




Чистый доход Изменить Дата
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
ALKERMES USD -66.48M 115.82M 2026-03
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Amgen USD 1.82B 486M 2026-03
Baxter International USD -15M 1.11B 2026-03
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Biogen USD 319.5M 368.4M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Cara Therapeutics USD -5.53M 621K 2025-09
Cipla INR 6.76B 6.75B 2025-12
Dr.Reddys Laboratories INR 2.21B 9.89B 2026-03
Eisai JPY 17.18B 7.02B 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Exelixis USD 210.47M 34.06M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Grifols EUR 114.37M 34.03M 2025-12
Halozyme Therapeutics USD 150.05M 291.64M 2026-03
Incyte USD 303.33M 4.05M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
MacroGenics USD -14.16M 30.98M 2025-12
Merck USD -4.24B 7.2B 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Neurocrine Biosciences USD 197.9M 44.2M 2026-03
Novartis USD 3.16B 747M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Takeda JPY -24.32B 127.96B 2026-03
Teva Pharmaceutical Industries USD 369M 111M 2026-03
Xencor USD -128.92M 122.26M 2026-03